Loading stock data…
Satellos Bioscience Inc. (MSLE)
$9.62-0.16 (-1.64%)
Market ClosedLast close Jul 23
Satellos Bioscience Inc., a clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Satellos Bioscience Inc. in the Healthcare sector is trading at $9.62 with a market capitalization of $145M. Wall Street consensus targets $27.67 (3 analysts), implying a +187.6% move over the next 12 months. The stock is currently 28% below its 52-week high of $13.39, remaining 26.1% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the safe zone. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +187.6% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -$10.04M↓ | -$7.65M↓ | -$5.97M↑ | -$6.37M↑ | -$6.48M |
| Net Income | -$9.77M↓ | -$7.30M↓ | -$5.82M↓ | -$5.61M↑ | -$6.14M |
Peer Comparison
JNJUNHPFE
Fundamentals
Satellos Bioscience Inc., a clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia. The company uses its proprietary discovery p...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$144.78M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.19
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-40.33%
Volume
Today's trading volume
108,705
Recent News
Satellos Bioscience DMD Drug Shows Early Promise in 6-Month Study Update
Satellos Bioscience (NASDAQ:MSLE) said interim six-month data from its ongoing TRAILHEAD study showed encouraging safety and efficacy signals for SAT-3247, its investigational therapy for Duchenne muscular dystrophy, in a small cohort of adult participants. The company reported results from four ad
Satellos Bioscience Duchenne Drug Candidate's Interim Data Boosts Confidence
Recently listed, Satellos Bioscience Inc. (NASDAQ:MSLE) on Wednesday reported six-month interim data from its ongoing TRAILHEAD study of SAT-3247 for Duchenne muscular dystrophy (DMD) The data showed that SAT-3247-treated DMD patients experienced improvements in muscle composition and upper limb activity while maintaining stable strength. The company also said the drug continued to demonstrate a favorable safety and tolerability profile, supporting its continued clinical development. Read Also:
Satellos Says Interim Phase 2 Data Shows SAT-3247 Improves Muscle Measures in Adult DMD Patients
Satellos Bioscience (MSLE) said Wednesday six-month interim data from a phase 2 trial showed that it
We're Not Very Worried About Satellos Bioscience's (TSE:MSCL) Cash Burn Rate
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Here Are Monday’s Top Wall Street Analyst Research Calls: Avis Budget, Carvana, Dow, Kratos Defense, Netflix, Northern Trust, PayPay,Twilio, Tyson Foods and More
Pre-Market Stock Futures: Futures are trading mixed as we get ready to kick off the first-quarter earnings season next week, and, as usual, the big money-center banks and brokerage firms will headline the first results. All of the major U.S. indices saw wild swings on Thursday, and after opening the day deep in the red, ... Here Are Monday’s Top Wall Street Analyst Research Calls: Avis Budget, Carvana, Dow, Kratos Defense, Netflix, Northern Trust, PayPay,Twilio, Tyson Foods and More